ARTICLE | Clinical News
Cicletanine: Phase II started
March 30, 2009 7:00 AM UTC
Gilead began a double-blind, placebo-controlled, international Phase II trial to evaluate 150 mg of oral cicletanine given once or twice daily or 300 mg given once daily for 12 weeks in 160 patients. ...